Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-3 Shelf registration
- 1.2 Open Market Sale Agreementsm, Dated June 5, 2020, by and Between AYTU Bioscience, Inc. and Jefferies
- 4.14 Form of Indenture
- 5.1 Opinion of Dorsey & Whitney LLP
- 5.2 Opinion of Dorsey & Whitney LLP
- 23.2 Consent of Plante & Moran, PLLC Relating to Aytu's Financial Statements
- 23.3 Consent of Hall & Company Relating to Innovus' Financial Statements.
- 23.4 Consent of Ernst & Young LLP, Independent Auditors of the Abbreviated Financial Statements of the Pediatrics Product Portfolio of Cerecor Inc.
- 23.5 Consent of Eks&h LLLP, Predecessor Independent Public Accounting Firm, Relating to Aytu's Financial Statements
- 99.1 Unaudited Pro Forma Condensed Combined Statement of Operations for the Year Ended June 30, 2019 and Nine Months Ended March 31, 2020
Associated filings
- 14 Nov 22 424B5 Prospectus supplement for primary offering
- 4 Jun 21 424B3 Prospectus supplement
- 4 Jun 21 424B5 Prospectus supplement for primary offering
- 14 Dec 20 424B5 Prospectus supplement for primary offering
- 11 Dec 20 FWP Free writing prospectus
- 10 Dec 20 FWP Free writing prospectus
- 10 Dec 20 424B5 Prospectus supplement for primary offering
- 18 Jun 20 EFFECT Notice of effectiveness
-
8 Jun 20 S-3 Shelf registration
AYTU similar filings
Filing view
External links